Literature DB >> 22998694

Safety of erythropoiesis-stimulating agents in patients with end-stage kidney disease: data are safer than extrapolations.

Ivo Abraham, Karen MacDonald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22998694     DOI： 10.1517/14740338.2012.726611

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN： 1474-0338            Impact factor:   4.250


× No keyword cloud information.
  1 in total

1.  Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study).

Authors:  Loreto Gesualdo; Christian Combe; Adrian Covic; Frank Dellanna; David Goldsmith; Gérard London; Johannes F Mann; Philippe Zaoui; Matthew Turner; Mike Muenzberg; Karen MacDonald; Ivo Abraham
Journal:  Int Urol Nephrol       Date:  2015-04-17       Impact factor: 2.370
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.